# PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

> **NIH NIH N02** · UNIVERSITY OF WISCONSIN-MADISON · 2022 · $296,637

## Abstract

The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.

## Key facts

- **NIH application ID:** 10674471
- **Project number:** 261201200033I-P00008-26100011-1
- **Recipient organization:** UNIVERSITY OF WISCONSIN-MADISON
- **Principal Investigator:** HOWARD BAILEY
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $296,637
- **Award type:** —
- **Project period:** 2017-09-15 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10674471

## Citation

> US National Institutes of Health, RePORTER application 10674471, PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER (261201200033I-P00008-26100011-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10674471. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*